Evidence map›Paper›PMID 33042434›Full record

ArticleAmerican journal of translational research2020

Antitumor properties of arsenic trioxide-loaded CalliSpheres

Xuhua Duan, Hao Li, Xinwei Han, Jianzhuang Ren, Fengyao Li, Shuguang Ju, Manzhou Wang, Wenhui Wang

Abstract read
In one paragraph

Article in American journal of translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Nrf2-siRNA Enhanced the Anti-Tumor Effects of AsJournal of hepatocellular carcinoma · 2022
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xuhua DuanDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.
Hao LiDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.
Xinwei HanDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.
Jianzhuang RenDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.
Fengyao LiDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.
Shuguang JuDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.
Manzhou WangDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.
Wenhui WangDepartment of Interventional Radiology, The First Affiliated Hospital, Zhengzhou University Zhengzhou, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the antitumor effect of arsenic trioxide (ATO)-loaded CalliSpheres

Indexed as

Arsenic trioxideCalliSpheres® microspheresdrug-eluting beads-transarterial chemoembolizationhepatocellular carcinomatumor progression

Identifiers

PMID33042434
PMCPMC7540148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.